Michael Klagsbrun Selected Research

Michael Klagsbrun Research Topics

Disease

31	Neoplasms (Cancer) 07/2015 - 01/2002
6	Neoplasm Metastasis (Metastasis) 01/2013 - 11/2004
3	Inflammation (Inflammations) 11/2016 - 01/2005
3	Glioblastoma (Glioblastoma Multiforme) 05/2014 - 05/2011
3	Melanoma (Melanoma, Malignant) 05/2011 - 08/2010
3	Colonic Neoplasms (Colon Cancer) 01/2011 - 06/2004
2	Hydrocephalus (Hydrocephaly) 01/2016 - 09/2013
2	Hemangioma (Angioma) 08/2015 - 01/2015
2	Medulloblastoma 07/2014 - 02/2013
2	Brain Neoplasms (Brain Tumor) 01/2013 - 02/2012
2	Hypoxia (Hypoxemia) 05/2011 - 07/2002
1	Lymphedema (Milroy Disease) 11/2016
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2016
1	Carcinoma (Carcinomatosis) 08/2015
1	Skin Neoplasms (Skin Cancer) 07/2015
1	Pathologic Neovascularization 06/2013
1	Neurilemmoma (Schwannoma) 02/2012
1	Vascular Diseases (Vascular Disease) 12/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Aneuploidy (Aneuploid) 12/2009
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2009
1	Glioma (Gliomas) 10/2008
1	Vascular Calcification 09/2008
1	Cataract (Cataracts) 07/2006
1	Edema (Dropsy) 01/2005
1	Hypersensitivity (Allergy) 01/2005
1	Nevus (Nevi) 11/2004
1	Hyperplasia 11/2004

Drug/Important Bio-Agent (IBA)

12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 03/2002
10	Semaphorins (Semaphorin)IBA 08/2015 - 11/2004
7	NeuropilinsIBA 01/2011 - 01/2002
6	Neuropilin-2IBA 11/2016 - 11/2004
6	Proteins (Proteins, Gene)FDA Link 07/2015 - 12/2007
4	Messenger RNA (mRNA)IBA 07/2014 - 06/2004
4	Phosphotransferases (Kinase)IBA 05/2014 - 02/2006
4	Epidermal Growth Factor (EGF)IBA 05/2008 - 07/2002
4	ErbB Receptors (EGF Receptor)IBA 05/2008 - 07/2002
3	Netrin-1IBA 01/2016 - 01/2013
3	Angiogenesis InhibitorsIBA 09/2013 - 11/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2013 - 07/2002
3	Neuropilin-1IBA 02/2013 - 03/2003
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2016 - 07/2002
2	neogeninIBA 01/2016 - 07/2014
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2015 - 01/2015
2	Semaphorin-3AIBA 05/2014 - 01/2002
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2013 - 03/2002
2	Actins (F Actin)IBA 05/2011 - 01/2008
2	Transcription Factors (Transcription Factor)IBA 05/2010 - 01/2002
2	AntibodiesIBA 12/2007 - 04/2007
2	Mitogen-Activated Protein KinasesIBA 02/2006 - 06/2004
1	GalactosidasesIBA 01/2016
1	lysophosphatidylinositolIBA 08/2015
1	4- (4- (3- hydroxyphenyl)- 3- (4- methylphenyl)- 6- oxo- 1H,4H,5H,6H- pyrrolo(3,4- c)pyrazol- 5- yl)benzoic acidIBA 08/2015
1	EndocannabinoidsIBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	Imatinib Mesylate (Gleevec)FDA Link 05/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2013
1	matrigelIBA 01/2013
1	Cysteine Proteases (Cysteine Protease)IBA 01/2013
1	EnzymesIBA 01/2013
1	Cathepsin BIBA 01/2013
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2013
1	Annexin A2 (Annexin II)IBA 01/2013
1	Metalloproteases (Metalloproteinases)IBA 11/2012
1	GTP Phosphohydrolases (GTPases)IBA 11/2012
1	ADP-Ribosylation Factor 6IBA 11/2012
1	RNA (Ribonucleic Acid)IBA 11/2012
1	Caveolin 1IBA 11/2012
1	Neurofibromin 2 (Merlin)IBA 02/2012
1	Retinaldehyde (Retinal)IBA 12/2011
1	Conditioned Culture MediaIBA 05/2011
1	Deferoxamine (Desferal)FDA LinkGeneric 05/2011
1	Keratin-20 (Cytokeratin 20)IBA 01/2011
1	VimentinIBA 01/2011
1	Cadherins (E-Cadherin)IBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 10/2010
1	Bevacizumab (Avastin)FDA Link 08/2010
1	plexinIBA 08/2010
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2010
1	DNA ProbesIBA 12/2009
1	Advanced Glycation End ProductsIBA 03/2009
1	Actin Depolymerizing Factors (Cofilins)IBA 10/2008
1	ARG tyrosine kinaseIBA 10/2008
1	OsteopontinIBA 09/2008
1	OsteocalcinIBA 09/2008
1	Phenobarbital (Luminal)FDA Link 09/2008
1	GelsIBA 08/2008
1	Y 27632IBA 08/2008
1	Gefitinib (Iressa)FDA Link 05/2008
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2008
1	Neutralizing AntibodiesIBA 12/2007
1	gamma-CrystallinsIBA 07/2006
1	Crystallins (Crystallin)IBA 07/2006
1	LigandsIBA 08/2005
1	CollagenIBA 11/2004
1	Fibronectins (Fibronectin)IBA 11/2004

Therapy/Procedure

6	Therapeutics 02/2013 - 02/2006
1	Aftercare (After-Treatment) 05/2011
1	Traction 08/2008